This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Barry S. Fogel, MD
Departments of Psychiatry and Neurology Brown University Providence, RI 02912

Arch Neurol. 1986;43(2):105.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Reding et al¹ have reported on dexamethasone suppression tests (DSTs) in stroke, and found that they correlate with depression but are not predictive of rehabilitation outcome. Unfortunately, their study has not specified whether and how patients' depressions were treated. If the depressed patients received treatment, the effect of treatment outcome on rehabilitation outcome would require assessment. If the patients with depression were not treated, ethical questions could be raised.

Furthermore, two methodologic points need attention. First, the authors lumped dysthymic disorder and major depressive disorder together as "depression." In most of the psychiatric DST literature, it is major depression that is associated with abnormal DST results. A 49% prevalence of abnormal DST results in dysthymic disorders would be highly unusual. Thus, it would be useful to know how the patients were divided into major depressed and dysthymic groups. Second, the authors employed a 5-µg/dL cutoff for . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?